Hanmi Eyes Digital Healthcare As Next Growth Engine

But Calls For More Supportive Domestic Regulations

Hanmi’s head of new product development elucidated the leading Korean pharma firm’s digital healthcare strategy at a recent domestic forum, including plans for the country’s first medicine/DTx combo, and shared views on what is needed to improve the domestic regulatory and market environment.

Na Young Kim, head of new product development, Hanmi Pharm
Hanmi Developing Korea’s First Medicine Plus DTx Combo • Source: Jung Won Shin

More from South Korea

More from Focus On Asia